AUTHOR=Lakomy Radek , Kazda Tomas , Selingerova Iveta , Poprach Alexandr , Pospisil Petr , Belanova Renata , Fadrus Pavel , Vybihal Vaclav , Smrcka Martin , Jancalek Radim , Hynkova Ludmila , Muckova Katarina , Hendrych Michal , Sana Jiri , Slaby Ondrej , Slampa Pavel TITLE=Real-World Evidence in Glioblastoma: Stupp's Regimen After a Decade JOURNAL=Frontiers in Oncology VOLUME=10 YEAR=2020 URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.00840 DOI=10.3389/fonc.2020.00840 ISSN=2234-943X ABSTRACT=
The aim of this retrospective study is to provide real-world evidence in glioblastoma treatment and to compare overall survival after Stupp's regimen treatment today and a decade ago. A current consecutive cohort of histologically confirmed glioblastoma irradiated from 1/2014 to 12/2017 in our cancer center was compared with an already published historical control of patients treated in 1/2003–12/2009. A total of new 155 patients was analyzed, median age 60.9 years, 61% men, 58 patients (37%) underwent gross total tumor resection. Stupp's regimen was indicated in 90 patients (58%), 65 patients (42%) underwent radiotherapy alone. Median progression-free survival in Stupp's regimen cohort was 6.7 months, median OS 16.0 months, and 2-year OS 30.7%. OS was longer if patients were able to finish at least three cycles of adjuvant chemotherapy (median 23.3 months and 43.9% of patients lived at 2 years after surgery). Rapid early progression prior to radiotherapy was a negative prognostic factor with HR 1.87 (